Jilin biopharmaceutical company in Tonghua, the first in China to bring human insulin to market with the recombinant product Gansulin in 1998, making insulin products and analogues alongside traditional Chinese and chemical medicines, insulin delivery devices and chronic disease management services.
No comments available.
Leave your rating & comment